WO2003074062A3 - Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals - Google Patents
Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals Download PDFInfo
- Publication number
- WO2003074062A3 WO2003074062A3 PCT/IB2003/000824 IB0300824W WO03074062A3 WO 2003074062 A3 WO2003074062 A3 WO 2003074062A3 IB 0300824 W IB0300824 W IB 0300824W WO 03074062 A3 WO03074062 A3 WO 03074062A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bioactive component
- extract
- tumor
- inflammatory
- med
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0308253A BRPI0308253A2 (en) | 2002-03-07 | 2003-03-07 | Isolation, purification and structural identification of a bioactive component of a water-soluble extract of a botanical species to enhance immune, anti-inflammatory, antitumor and DNA repair processes of warm-blooded animals |
CA002477785A CA2477785A1 (en) | 2002-03-07 | 2003-03-07 | Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
KR10-2004-7013931A KR20040099300A (en) | 2002-03-07 | 2003-03-07 | Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
IL16388603A IL163886A0 (en) | 2002-03-07 | 2003-03-07 | Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune,anti-inflammatory, anti-tumor and dna repair proc esses of warm blooded animals |
MXPA04008567A MXPA04008567A (en) | 2002-03-07 | 2003-03-07 | Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals. |
EP03704896A EP1485114A2 (en) | 2002-03-07 | 2003-03-07 | Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
AU2003207894A AU2003207894A1 (en) | 2002-03-07 | 2003-03-07 | Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
JP2003572579A JP2005526053A (en) | 2002-03-07 | 2003-03-07 | Isolation, purification, and structural identification of bioactive components of water-soluble extracts of plant species to promote the process of warm-blooded animal immunity, anti-inflammatory, anti-tumor, and DNA repair |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/093,794 | 2002-03-07 | ||
US10/093,794 US6964784B2 (en) | 2002-03-07 | 2002-03-07 | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003074062A2 WO2003074062A2 (en) | 2003-09-12 |
WO2003074062A3 true WO2003074062A3 (en) | 2004-02-05 |
Family
ID=27788020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2003/000824 WO2003074062A2 (en) | 2002-03-07 | 2003-03-07 | Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
Country Status (11)
Country | Link |
---|---|
US (7) | US6964784B2 (en) |
EP (1) | EP1485114A2 (en) |
JP (1) | JP2005526053A (en) |
KR (1) | KR20040099300A (en) |
CN (1) | CN1649610A (en) |
AU (1) | AU2003207894A1 (en) |
BR (1) | BRPI0308253A2 (en) |
CA (1) | CA2477785A1 (en) |
IL (1) | IL163886A0 (en) |
MX (1) | MXPA04008567A (en) |
WO (1) | WO2003074062A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4708675B2 (en) * | 2000-11-03 | 2011-06-22 | プロテオテック・インコーポレーテッド | Method for isolating amyloid inhibitory compounds from Uncaria tomentosa and related plants and use of the isolated compounds |
US6964784B2 (en) * | 2002-03-07 | 2005-11-15 | Optigenex, Inc. | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
US20040220119A1 (en) | 2003-04-04 | 2004-11-04 | Unigen Pharmaceuticals, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
PL1762219T3 (en) † | 2004-04-01 | 2013-06-28 | Cantabria Ind Farmaceutica Sa | Photoprotective and/or photoimmunoprotective compositions for the skin and uses thereof |
US20050226825A1 (en) * | 2004-04-13 | 2005-10-13 | Giampapa Vincent C | Topical composition for preventing and treating skin damage caused by UV light exposure |
US20050287227A1 (en) * | 2004-04-16 | 2005-12-29 | Ronald Pero | Supplement containing carotenoid, nicotinamide, zinc, water soluble extract of uncaria species and method of the same |
KR100545304B1 (en) * | 2004-09-01 | 2006-05-08 | 주식회사 유니젠 | Composition comprising uncaria genus plant having uncaria gambir, or scutellaria radix and/or green tea extract mixture for suppressing cyclooxygenase or 5-lipoxygenase |
RU2007138220A (en) * | 2005-03-16 | 2009-04-27 | Рональд В. ПЕРО (SE) | MEDICAL COMPOSITIONS OF SALTS, CHELATES AND / OR FREE ACIDS, ORGANIC ACIDS WITH ALPHA HYDROXYL AND RELATED PROCESSES AND METHODS |
US20090035395A1 (en) * | 2007-08-01 | 2009-02-05 | Peter Koepke | Spondias mombin l. extract and methods of extracting and using such extract |
US7879369B2 (en) | 2007-09-18 | 2011-02-01 | Selvamedica, Llc | Combretum laurifolium Mart. extract and methods of extracting and using such extract |
EP2219445A4 (en) * | 2007-11-09 | 2013-05-29 | Univ Tennessee Res Foundation | Anti-inflammatory quinic acid derivatives for oral administration |
AU2009322474A1 (en) * | 2008-12-01 | 2011-07-21 | Lifespan Extension Llc | Methods and compositions for altering health, wellbeing, and lifespan |
US8911774B2 (en) * | 2009-05-18 | 2014-12-16 | Cellhealth Technologies Ltd. | Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use |
US9457009B2 (en) | 2012-05-31 | 2016-10-04 | The United States Of America As Represented By The Department Of Veterans Affairs | Methods and compositions for preventing and treating auditory dysfunctions |
KR102237799B1 (en) | 2012-11-14 | 2021-04-08 | 더블유.알. 그레이스 앤드 캄파니-콘. | Compositions containing a biologically active material and a non-ordered inorganic oxide |
US20180042875A1 (en) * | 2015-03-03 | 2018-02-15 | Nestec S.A. | Compound use in promoting energy expenditure |
US10098922B1 (en) * | 2017-11-30 | 2018-10-16 | Optigenex, Inc. | Increasing telomere length in a cell |
CN113759067A (en) * | 2021-08-06 | 2021-12-07 | 北京康仁堂药业有限公司 | Thin-layer chromatography construction method, identification method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6238675B1 (en) * | 1997-02-27 | 2001-05-29 | Campamed Corp. | Method of preparation and composition of a water soluble extract of the plant species Uncaria for enhancing immune, anti-inflammatory and anti-tumor processes of warm blooded animals |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE543969A (en) * | 1954-05-28 | |||
DE1905875A1 (en) * | 1969-02-06 | 1970-08-20 | Stark Dr Hans C | Preparation for regulation of menstruation - and its continuation for several years after |
US4363815A (en) * | 1975-07-23 | 1982-12-14 | Yu Ruey J | Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions |
US5385938B1 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of using glycolic acid for treating wrinkles |
US5389677B1 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of treating wrinkles using glycalic acid |
US4940803A (en) * | 1988-05-23 | 1990-07-10 | Merck & Co., Inc. | Process for synthesis of 1R,2R,5R-2-hydroxy-6-oxo-7-oxabicyclo[3.2.1]-octane |
DE69228542T2 (en) * | 1992-08-03 | 1999-07-29 | Nestle Sa | 3- and / or 4-substituted quinic acid derivatives and process for the preparation of 3- and / or 4-substituted quinic acid derivatives |
DE10299052I1 (en) * | 1995-02-27 | 2003-05-22 | Gilead Sciences Inc | New selective inhibitors of viral or bacterial neuraminidases |
US6039949A (en) * | 1997-02-27 | 2000-03-21 | Campamed, Inc. | Method of preparation and composition of a water soluble extract of the plant species uncaria |
US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
TW480247B (en) * | 1997-12-12 | 2002-03-21 | Gilead Sciences Inc | Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same |
JPH11245503A (en) * | 1998-03-02 | 1999-09-14 | Bando Chem Ind Ltd | Water ink absorbing material and laminate film having layer of the absorbing material |
EP2275540B1 (en) * | 1999-04-09 | 2016-03-23 | Kyowa Hakko Kirin Co., Ltd. | Method for controlling the activity of immunologically functional molecule |
US6723368B1 (en) * | 1999-12-21 | 2004-04-20 | Loretta M. Zapp | Method for enhancing post-processing content of beneficial compounds in beverages naturally containing same |
US20010047032A1 (en) * | 1999-12-30 | 2001-11-29 | Castillo Gerardo M. | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
US6410246B1 (en) * | 2000-06-23 | 2002-06-25 | Genetastix Corporation | Highly diverse library of yeast expression vectors |
US7449308B2 (en) * | 2000-06-28 | 2008-11-11 | Glycofi, Inc. | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
US20060029604A1 (en) * | 2000-06-28 | 2006-02-09 | Gerngross Tillman U | Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform |
US7795002B2 (en) * | 2000-06-28 | 2010-09-14 | Glycofi, Inc. | Production of galactosylated glycoproteins in lower eukaryotes |
US7598055B2 (en) * | 2000-06-28 | 2009-10-06 | Glycofi, Inc. | N-acetylglucosaminyltransferase III expression in lower eukaryotes |
US20060034830A1 (en) * | 2000-06-28 | 2006-02-16 | Gerngross Tillman U | Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform |
US20060034828A1 (en) * | 2000-06-28 | 2006-02-16 | Gerngross Tillman U | Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform |
KR100787073B1 (en) * | 2000-06-28 | 2007-12-21 | 글리코파이, 인크. | Methods for producing modified glycoproteins |
US20060024304A1 (en) * | 2000-06-28 | 2006-02-02 | Gerngross Tillman U | Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform |
US7863020B2 (en) * | 2000-06-28 | 2011-01-04 | Glycofi, Inc. | Production of sialylated N-glycans in lower eukaryotes |
US20050260729A1 (en) * | 2004-03-17 | 2005-11-24 | Hamilton Stephen R | Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
US7625756B2 (en) * | 2000-06-28 | 2009-12-01 | GycoFi, Inc. | Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
GB0108903D0 (en) * | 2000-10-05 | 2001-05-30 | Aventis Pharm Prod Inc | Novel crystalline forms of a factor Xa inhibitor |
US7064191B2 (en) * | 2000-10-06 | 2006-06-20 | Kyowa Hakko Kogyo Co., Ltd. | Process for purifying antibody |
US6632459B2 (en) * | 2000-12-11 | 2003-10-14 | Nutricia N.V. | Chlorogenic acid and an analog thereof for immune system stimulation |
CA2347879A1 (en) * | 2001-05-11 | 2002-11-11 | Vanderbilt University | Substituted dicinnamoylquinides and their use in augmentation of adenosine function |
US20060024292A1 (en) * | 2001-12-27 | 2006-02-02 | Gerngross Tillman U | Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform |
US20060034829A1 (en) * | 2001-12-27 | 2006-02-16 | Gerngross Tillman U | Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform |
ES2402527T3 (en) * | 2001-12-27 | 2013-05-06 | Glycofi, Inc. | Procedures for obtaining mammalian carbohydrate structures by genetic engineering |
US6964784B2 (en) * | 2002-03-07 | 2005-11-15 | Optigenex, Inc. | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
US7332299B2 (en) * | 2003-02-20 | 2008-02-19 | Glycofi, Inc. | Endomannosidases in the modification of glycoproteins in eukaryotes |
JP4861830B2 (en) * | 2003-12-24 | 2012-01-25 | グライコフィ, インコーポレイテッド | Method for removing mannosyl phosphorylation of glycans in glycoprotein production |
AU2005238308B8 (en) * | 2004-04-29 | 2009-10-08 | Glycofi, Inc. | Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins |
-
2002
- 2002-03-07 US US10/093,794 patent/US6964784B2/en not_active Expired - Lifetime
-
2003
- 2003-03-07 EP EP03704896A patent/EP1485114A2/en not_active Withdrawn
- 2003-03-07 IL IL16388603A patent/IL163886A0/en unknown
- 2003-03-07 KR KR10-2004-7013931A patent/KR20040099300A/en not_active Application Discontinuation
- 2003-03-07 JP JP2003572579A patent/JP2005526053A/en active Pending
- 2003-03-07 CN CNA038101599A patent/CN1649610A/en active Pending
- 2003-03-07 AU AU2003207894A patent/AU2003207894A1/en not_active Abandoned
- 2003-03-07 CA CA002477785A patent/CA2477785A1/en not_active Abandoned
- 2003-03-07 WO PCT/IB2003/000824 patent/WO2003074062A2/en active Application Filing
- 2003-03-07 BR BRPI0308253A patent/BRPI0308253A2/en not_active Application Discontinuation
- 2003-03-07 MX MXPA04008567A patent/MXPA04008567A/en unknown
-
2004
- 2004-10-21 US US10/970,144 patent/US7595064B2/en not_active Expired - Lifetime
-
2005
- 2005-11-09 US US11/270,235 patent/US7579023B2/en not_active Expired - Lifetime
-
2009
- 2009-05-28 US US12/473,396 patent/US7947312B2/en not_active Expired - Fee Related
- 2009-07-17 US US12/504,845 patent/US7955626B2/en not_active Expired - Fee Related
-
2011
- 2011-05-18 US US13/110,603 patent/US8372449B2/en not_active Expired - Lifetime
- 2011-05-18 US US13/110,557 patent/US8372448B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6238675B1 (en) * | 1997-02-27 | 2001-05-29 | Campamed Corp. | Method of preparation and composition of a water soluble extract of the plant species Uncaria for enhancing immune, anti-inflammatory and anti-tumor processes of warm blooded animals |
Non-Patent Citations (2)
Title |
---|
ANNA CAPASSO ET AL.: "Phytochemical and Pharmacological Studies of Guettarda acreana", PLANTA MEDICA, vol. 64, no. 4, May 1998 (1998-05-01), pages 348 - 352, XP009013539 * |
SUZUKI A ET AL: "GREEN COFFEE BEAN EXTRACT AND ITS METABOLITES HAVE A HYPOTENSIVE EFFECT IN SPONTANEOUSLY HYPERTENSIVE RATS", HYPERTENSION RESEARCH. CLINICAL AND EXPERIMENTAL, OSAKA, JP, vol. 25, no. 1, 2002, pages 99 - 107, XP008007437, ISSN: 0916-9636 * |
Also Published As
Publication number | Publication date |
---|---|
IL163886A0 (en) | 2005-12-18 |
US20060068035A1 (en) | 2006-03-30 |
US7955626B2 (en) | 2011-06-07 |
MXPA04008567A (en) | 2004-12-06 |
US20110263706A1 (en) | 2011-10-27 |
AU2003207894A1 (en) | 2003-09-16 |
US8372448B2 (en) | 2013-02-12 |
WO2003074062A2 (en) | 2003-09-12 |
EP1485114A2 (en) | 2004-12-15 |
US7595064B2 (en) | 2009-09-29 |
US7579023B2 (en) | 2009-08-25 |
US6964784B2 (en) | 2005-11-15 |
CA2477785A1 (en) | 2003-09-12 |
US7947312B2 (en) | 2011-05-24 |
JP2005526053A (en) | 2005-09-02 |
KR20040099300A (en) | 2004-11-26 |
US8372449B2 (en) | 2013-02-12 |
BRPI0308253A2 (en) | 2016-07-12 |
US20110245337A1 (en) | 2011-10-06 |
US20090298939A1 (en) | 2009-12-03 |
US20050176825A1 (en) | 2005-08-11 |
CN1649610A (en) | 2005-08-03 |
US20090281180A1 (en) | 2009-11-12 |
US20030170320A1 (en) | 2003-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003074062A3 (en) | Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals | |
Al-Shamma et al. | Antimicrobial agents from higher plants. Antimicrobial agents from Peganum harmala seeds | |
Chen et al. | Pinelloside, an antimicrobial cerebroside from Pinellia ternata | |
Tamés et al. | Growth substances isolated from tubers of Cyperus esculentus var. aureus | |
KR100770746B1 (en) | .nobiletin from citrus having anti-inflammation activity and the method of separation and purify | |
Bhardwaj et al. | Hepatotoxicity and cholestasis in rats induced by the sesquiterpene, 9‐oxo‐10, 11‐dehydroageraphorone, isolated from Eupatorium adenophorum | |
EP0006060A1 (en) | Inula extract, process for preparing it and its use as a medicament | |
Fatima et al. | Quinovic acid glycosides from Mitragyna stipulosa-first examples of natural inhibitors of snake venom phosphodiesterase I | |
KR101902317B1 (en) | Enzyme treated Mugunghwa extracts for improving skin wrinkle | |
Heuser et al. | Isolation of Three Lipid Root-Initiating Substances from Juvenile Hedera helix Shoot Tissue1 | |
Ishikura et al. | Effects of glyphosate on caffeic acid metabolism in Perilla cell suspension cultures | |
Filho et al. | Constituents of the stem-bark of Zizyphus joazeiro | |
Wee et al. | Analysis of phenolic components in Korean red ginseng by GC/MS | |
Takahashi et al. | Changes of cyclic AMP and cyclic GMP levels during germination of pine pollen | |
Jin et al. | Identification of a Taq DNA polymerase inhibitor from the red seaweed Symphyocladia latiuscula | |
El-Mawla et al. | Production of flavonoids in cell cultures of Astragalus sieberi DC | |
Joseph | The cytokinins of Cichorium intybus L. root: identification and changes during vernalization | |
KR20140148226A (en) | A composition having activity of blood glucose regulation and aldose reductase inhibition comprising the extract of magnolia grandiflora l. as an active ingredient for preventing and treating diabetic complications | |
WO2000056347A1 (en) | An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof | |
RU2045271C1 (en) | Method for preparing agent having antitumoral activity | |
Teramoto et al. | The formation of catechin and procyanidins in cell suspension cultures of Cryptomeria japonica | |
Leshem et al. | The selective effect of abscisic acid on ribonucleic acid components | |
NAITO et al. | Fractionation of Antioxidants from Cacao Bean Husk Studies on Natural Antioxidant Part IV | |
KR20060095274A (en) | Method for extracting quercitrin from a propolis | |
Ataa et al. | Antitumor activity of Ailanthus excelsa (Roxb) stem bark fractions and Canthin-6-one |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2477785 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 163886 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/008567 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003572579 Country of ref document: JP Ref document number: 1020047013931 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 535356 Country of ref document: NZ Ref document number: 2003207894 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003704896 Country of ref document: EP Ref document number: 200408104 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038101599 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020047013931 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003704896 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: PI0308253 Country of ref document: BR Free format text: APRESENTE DOCUMENTOS COMPROBATORIOS QUE EXPLIQUEM A DIVERGENCIA NO NOME DO DEPOSITANTE CONSTANTE NA PUBLICACAO INTERNACIONAL WO 2003/074062 DE 12/09/2003 "PERO, RONALD, W." E O CONSTANTE DA PETICAO NO 860140046842 DE 07/04/2014 "OPTIGENEX, INC". |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01Y Ref document number: PI0308253 Country of ref document: BR Kind code of ref document: A2 Free format text: ANULADA A EXIGENCIA PUBLICADA NA RPI NO 2372 DE 21/06/2016, POR TER SIDO INDEVIDA. |
|
ENP | Entry into the national phase |
Ref document number: PI0308253 Country of ref document: BR Kind code of ref document: A2 Effective date: 20040906 |